87 related articles for article (PubMed ID: 11109838)
1. [Hematopoietic stem cell transplantation and aging].
Imamura M
Nihon Ronen Igakkai Zasshi; 2000 Sep; 37(9):709-11. PubMed ID: 11109838
[No Abstract] [Full Text] [Related]
2. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
Morishita Y
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
[No Abstract] [Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation: current issues and future prospects.
Socié G; Gluckman E
Ann Med Interne (Paris); 1999 Dec; 150(8):642-55. PubMed ID: 10686646
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia and graft-vs-host disease after hematopoietic stem cell transplantation.
Thiruvenkatarajan V; Rebecca J
Paediatr Anaesth; 2007 Jan; 17(1):7-15. PubMed ID: 17184425
[No Abstract] [Full Text] [Related]
5. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.
Ju Z; Jiang H; Jaworski M; Rathinam C; Gompf A; Klein C; Trumpp A; Rudolph KL
Nat Med; 2007 Jun; 13(6):742-7. PubMed ID: 17486088
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cells and the aging hematopoietic system.
Gazit R; Weissman IL; Rossi DJ
Semin Hematol; 2008 Oct; 45(4):218-24. PubMed ID: 18809091
[TBL] [Abstract][Full Text] [Related]
7. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation.
Wright-Kanuth MS; Smith LA
Clin Lab Sci; 2001; 14(2):112-7. PubMed ID: 15625984
[TBL] [Abstract][Full Text] [Related]
9. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
10. [Hematopoietic stem cell transplantation].
Sato N
Rinsho Byori; 2001 Mar; Suppl 115():103-10. PubMed ID: 11391926
[TBL] [Abstract][Full Text] [Related]
11. Jaundice after allogeneic hematopoietic stem cell transplantation.
Mendizabal M; Chen T; Reddy KR
Hepatology; 2009 Dec; 50(6):2044-5. PubMed ID: 19937681
[No Abstract] [Full Text] [Related]
12. [Indication of bone marrow transplantation].
Masaoka T
Rinsho Byori; 1995 Jul; Suppl 99():1-7. PubMed ID: 7474413
[No Abstract] [Full Text] [Related]
13. Lymphocyte subset recovery following allogeneic bone marrow transplantation: CD4(+)-cell count and transplant-related mortality.
Talmadge JE
Bone Marrow Transplant; 2008 Jan; 41(1):19-21. PubMed ID: 17934531
[No Abstract] [Full Text] [Related]
14. Current insights into ocular graft-versus-host disease.
Riemens A; te Boome L; Imhof S; Kuball J; Rothova A
Curr Opin Ophthalmol; 2010 Nov; 21(6):485-94. PubMed ID: 20729735
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
Koh LP; Koh MB; Ng HY; Hwang WY; Goh YT; Linn YC; Ng HJ; Chuah CT; Tan KW; Loh YS; Tan DC; Tan PH; Tan PH
Biol Blood Marrow Transplant; 2006 Aug; 12(8):887-90. PubMed ID: 16864060
[No Abstract] [Full Text] [Related]
16. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Kim I; Keam B; Lee KH; Kim JH; Oh SY; Ra EK; Yoon SS; Park SS; Kim CS; Park S; Hong YC; Kim BK
Clin Transplant; 2007; 21(2):207-13. PubMed ID: 17425746
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
[TBL] [Abstract][Full Text] [Related]
19. The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation.
Liu DH; Zhao XS; Chang YJ; Liu YK; Xu LP; Chen H; Han W; Chen YH; Wang Y; Huang XJ
Pediatr Blood Cancer; 2011 Jul; 57(1):135-41. PubMed ID: 21416583
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
